Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

1. WO2012003436 - PROCÉDÉS PERMETTANT DE TRAITER LE TROUBLE DE STRESS POST-TRAUMATIQUE

Numéro de publication WO/2012/003436
Date de publication 05.01.2012
N° de la demande internationale PCT/US2011/042785
Date du dépôt international 01.07.2011
CIB
A01N 43/00 2006.01
ANÉCESSITÉS COURANTES DE LA VIE
01AGRICULTURE; SYLVICULTURE; ÉLEVAGE; CHASSE; PIÉGEAGE; PÊCHE
NCONSERVATION DE CORPS HUMAINS OU ANIMAUX OU DE VÉGÉTAUX, OU DE PARTIES DE CEUX-CI; BIOCIDES, p.ex. EN TANT QUE DÉSINFECTANTS, PESTICIDES OU HERBICIDES; PRODUITS REPOUSSANT OU ATTIRANT LES ANIMAUX NUISIBLES; RÉGULATEURS DE CROISSANCE DES VÉGÉTAUX
43Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés hétérocycliques
C07D 205/00 2006.01
CCHIMIE; MÉTALLURGIE
07CHIMIE ORGANIQUE
DCOMPOSÉS HÉTÉROCYCLIQUES
205Composés hétérocycliques comportant des cycles à quatre chaînons ne contenant qu'un atome d'azote comme unique hétéro-atome du cycle
CPC
A61K 31/397
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
397having four-membered rings, e.g. azetidine
A61K 31/4178
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
41641,3-Diazoles
4178not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
A61K 31/422
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
42Oxazoles
422not condensed and containing further heterocyclic rings
A61K 31/439
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
439the ring forming part of a bridged ring system, e.g. quinuclidine
A61K 31/4439
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non condensed pyridines; Hydrogenated derivatives thereof
4427containing further heterocyclic ring systems
4439containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
A61K 31/454
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non condensed pyridines; Hydrogenated derivatives thereof
445Non condensed piperidines, e.g. piperocaine
4523containing further heterocyclic ring systems
454containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
Déposants
  • AZEVAN PHARMACEUTICALS, INC. [US/US]; 116 Research Drive Bethlehem, PA 18015, US (AllExceptUS)
  • BROWNSTEIN, Michael, J. [US/US]; US (UsOnly)
Inventeurs
  • BROWNSTEIN, Michael, J.; US
Mandataires
  • MCLAREN, Kevin, L.; Barnes & Thornburg LLP 11 South Meridian Street Indianapolis, IN 46204, US
Données relatives à la priorité
61/360,68601.07.2010US
Langue de publication anglais (EN)
Langue de dépôt anglais (EN)
États désignés
Titre
(EN) METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER
(FR) PROCÉDÉS PERMETTANT DE TRAITER LE TROUBLE DE STRESS POST-TRAUMATIQUE
Abrégé
(EN)
Compounds and compositions are described herein for treating post tramatic stress disorder.
(FR)
La présente invention se rapporte à des composés et à des compositions qui permettent de traiter le trouble de stress post-traumatique.
Autres publications associées
Dernières données bibliographiques dont dispose le Bureau international